The diffuse sclerosing osteomyelitis of the mandible treated by pamidronate administration

The diffuse sclerosing osteomyelitis of the mandible treated by pamidronate administration - The diffuse sclerosing osteomyelitis of the mandible treated by pamidronate administration

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007466

Enrollment

Registered

2012-03-09

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic diffuse sclerosing osteomyelitis of the mandible

Interventions

Injection of 30mg of pamidronate per once

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The case of ineffective against standard treatment

Exclusion criteria

Exclusion criteria: The case of effective against standard treatment

Design outcomes

Primary

Measure	Time frame
Evaluate the pain scale every two weeks and confirm the change of the bone with the CT image three months later	—

Countries

Japan

Contacts

Public ContactIzumi YOSHITOMI

Nagasaki University Graduate School of Biomedical Sciences Department of Clinical Oral Oncology

095-819-7699

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026